60 Day FRN

JSPEARS on DSK121TN23PROD with NOTICES1

Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices
Research and Quality (AHRQ) with
respect to activities proposed or
undertaken to carry out AHRQ’s
statutory mission. AHRQ produces
evidence to make health care safer,
higher quality, more accessible,
equitable, and affordable, and works
within the U.S. Department of Health
and Human Services and with other
partners to make sure that the evidence
is understood and used. Seven new
members will be appointed to replace
seven current members whose terms
will expire in November 2022.
DATES: Nominations should be received
on or before 60 days after date of
publication.
ADDRESSES: Nominations should be sent
by email to Jaime Zimmerman at
NationalAdvisoryCouncil@ahrq.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, AHRQ, at (301) 427–
1456.
SUPPLEMENTARY INFORMATION: 42 U.S.C.
299c provides that the Secretary shall
appoint to the Council twenty-one
appropriately qualified individuals. At
least seventeen members shall be
representatives of the public and at least
one member shall be a specialist in the
rural aspects of one or more of the
professions or fields listed below. In
addition, the Secretary designates, as ex
officio members, representatives from
other Federal agencies, principally
agencies that conduct or support health
care research, as well as Federal officials
the Secretary may consider appropriate.
42 U.S.C. 299c(c)(3).
Seven current members’ terms will
expire in November 2022. To fill these
positions, we are seeking individuals
who: (1) Are distinguished in the
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) are distinguished in the
fields of health care quality research or
health care improvement; (3) are
distinguished in the practice of
medicine; (4) are distinguished in other
health professions; (5) represent the
private health care sector (including
health plans, providers, and purchasers)
or are distinguished as administrators of
health care delivery systems; (6) are
distinguished in the fields of health care
economics, information systems, law,
ethics, business, or public policy; and
(7) represent the interests of patients
and consumers of health care, 42 U.S.C.
299c(c)(2). Individuals are particularly
sought with experience and success in
these activities. AHRQ will accept
nominations to serve on the Council in
a representative capacity.
The Council meets in the Washington,
DC, metropolitan area, generally in
Rockville, Maryland, approximately

VerDate Sep<11>2014

18:02 May 05, 2022

Jkt 256001

three times a year to provide broad
guidance to the Secretary and AHRQ’s
Director on the direction of and
programs undertaken by AHRQ.
Seven individuals will be selected by
the Secretary to serve on the Council
beginning with the meeting in the
spring of 2023. Members generally serve
3-year terms. Appointments are
staggered to permit an orderly rotation
of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that once a candidate is
nominated, AHRQ may consider that
nomination for future positions on the
Council.
The Department seeks a broad
geographic representation. In addition,
AHRQ conducts and supports research
concerning priority populations, which
include: Inner city; rural; low income;
minority; women; children; elderly; and
those with special health care needs,
including those who have disabilities,
need chronic care, or need end-of-life
health care. See 42 U.S.C. 299(c). AHRQ
also includes in its definition of priority
populations those groups identified in
Section 2(a) of Executive Order 13985 as
members of underserved communities:
Black, Latino, and Indigenous and
Native American persons, Asian
Americans and Pacific Islanders and
other persons of color; members of
religious minorities; lesbian, gay,
bisexual, transgender, and queer
(LGBTQ+) persons; persons with
disabilities; persons who live in rural
areas; and persons otherwise adversely
affected by persistent poverty or
inequality. Nominations of persons with
expertise in health care for these
priority populations are encouraged.
Dated: May 2, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–09728 Filed 5–5–22; 8:45 am]
BILLING CODE 4160–90–P

PO 00000

Frm 00068

Fmt 4703

Sfmt 4703

27149

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–22–0824; Docket No. CDC–2022–
0059]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled the National
Syndromic Surveillance Program
(NSSP). The NSSP promotes and
advances development of a syndromic
surveillance system for the timely
exchange of syndromic data.
DATES: CDC must receive written
comments on or before July 5, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0059 by any of the following methods:
• Federal eRulemaking Portal
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
SUMMARY:

E:\FR\FM\06MYN1.SGM

06MYN1

27150

Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices

(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.

JSPEARS on DSK121TN23PROD with NOTICES1

Proposed Project
National Syndromic Surveillance
Program (NSSP) (OMB Control No.
0920–0824, Exp. 7/31/2022)—
Revision—Center for Surveillance,
Epidemiology and Laboratory Services
(CSELS), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Syndromic surveillance uses
syndromic data and statistical tools to
detect, monitor, and characterize
unusual activity for further public
health investigation or response.
Syndromic data include electronic
extracts of electronic health records
(EHRs) from patient encounter data from
emergency departments, urgent care,
ambulatory care, and inpatient
healthcare settings, as well as laboratory
data. Though these data are being

VerDate Sep<11>2014

18:02 May 05, 2022

Jkt 256001

captured for different purposes, they are
monitored in near real-time as potential
indicators of an event, a disease, or an
outbreak of public health significance.
On the national level, these data are
used to improve nationwide situational
awareness and enhance responsiveness
to hazardous events and disease
outbreaks to protect America’s health,
safety, and security.
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002,
and was launched by the CDC in 2003.
The BioSense Program has since been
expanded into the National Syndromic
Surveillance Program (NSSP) which
promotes and advances development of
a syndromic surveillance system for the
timely exchange of syndromic data.
CDC requests a three-year approval for
a Revision for NSSP (OMB Control No.
0920–0824, Exp. 7/31/2022). This
Revision includes a request for approval
to continue to receive onboarding data
from state, local and territorial public
health departments about healthcare
facilities in their jurisdiction;
registration data needed to allow users
access to the BioSense Platform tools
and services; and data sharing
permissions so that state, local and
territorial health departments can share
data with other state, local and
territorial health departments and CDC.
NSSP features the BioSense Platform
and a collaborative Community of
Practice. The BioSense Platform is a
secure integrated electronic health
information system that CDC provides,
primarily for use by state, local and
territorial public health departments. It
includes standardized analytic tools and
processes that enable users to rapidly
collect, evaluate, share, and store
syndromic surveillance data. NSSP
promotes a Community of Practice in
which participants collaborate to
advance the science and practice of
syndromic surveillance. Health
departments use the BioSense Platform
to receive healthcare data from facilities
in their jurisdiction, conduct syndromic
surveillance, and share the data with
other jurisdictions and CDC.
The BioSense Platform provides the
ability to analyze healthcare encounter
data from EHRs, as well as laboratory
data. All EHR and laboratory data reside
in a cloud-enabled, web-based platform
that has authorization to operate from
CDC. The BioSense Platform sits in the
secure, private Government Cloud
which is simply used as a storage and
processing mechanism, as opposed to
on-site servers at CDC. This

PO 00000

Frm 00069

Fmt 4703

Sfmt 4703

environment provides users with easily
managed on-demand access to a shared
pool of configurable computing
resources such as networks, servers,
software, tools, storage, and services,
with limited need for additional IT
support. Each site (i.e., state or local
public health department) controls its
data within the cloud and is provided
with free secure data storage space with
tools for posting, receiving, controlling
and analyzing their data; an easy-to-use
data display dashboard; and a shared
environment where users can
collaborate and advance public health
surveillance practice. Each site is
responsible for creating its own data use
agreements with the facilities that are
sending the data, retains ownership of
any data it contributes to its exclusive
secure space, and can share data with
CDC or users from other sites.
NSSP has three different types of
information collection:
(1) Collection of onboarding data
about healthcare facilities needed for
state, local, and territorial public health
departments to submit EHR data to the
BioSense Platform;
(2) Collection of registration data
needed to allow users access to the
BioSense Platform tools and services;
and
(3) Collection of data sharing
permissions so that state and local
health departments can share data with
other state and local health departments
and CDC.
Healthcare data shared with CDC can
include: EHR data received by state and
local public health departments from
facilities including hospital emergency
departments and inpatient settings,
urgent care, and ambulatory care;
mortality data from state and local vital
statistics offices; laboratory tests ordered
and their results from a national private
sector laboratory company; and EHR
data from the Department of Defense
(DoD) and the Department of Health and
Human Services (HHS) National
Disaster Medical System (NDMS)
Disaster Medical Assistance Teams
(DMATs).
Respondents include state, local, and
territorial public health departments.
The only burden incurred by the health
departments are for submitting
onboarding data about facilities to CDC,
submitting registration data about users
to CDC, and setting up data sharing
permissions with CDC. The estimated
annual burden is 671 hours. There are
no costs to respondents other than their
time to participate.

E:\FR\FM\06MYN1.SGM

06MYN1

27151

Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Avg. burden
per response
(in hours)

Total burden
(in hours)

Form name

State, Local, and Territorial Public Health Departments.
State, Local, and Territorial Public Health Departments.
State, Local, and Territorial Public Health Departments.

Onboarding ...................

20

100

10/60

333

Registration ..................

20

100

10/60

333

Data Sharing Permissions.

20

1

15/60

5

Total ...............................................................

.......................................

........................

........................

........................

671

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–09787 Filed 5–5–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22EN; Docket No. CDC–2022–
0056]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on proposed collection project
titled Synopsis of State Oral Health
Programs. This project collects data on
state oral health infrastructure and
capacity, including select indicators to
monitor oral health status and trends
and compare to other states, to inform
planning and evaluation of oral health
programs and policies, to measure state
progress towards the Healthy People
oral health objectives, and to educate
the public and policy makers regarding
cross-cutting public health programs.
DATES: Written comments must be
received on or before July 5, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0056 by either of the following methods:
SUMMARY:

JSPEARS on DSK121TN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondents

VerDate Sep<11>2014

18:02 May 05, 2022

Jkt 256001

Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.

FOR FURTHER INFORMATION CONTACT:

Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00070

Fmt 4703

Sfmt 4703

The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Synopsis of State Oral Health
Programs—Existing Collection in Use
Without an OMB Control Number—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
This request is to collect information
about human resources, programs, and
infrastructure in oral health
departments within a state health
department for all 50 states and
Washington, DC. Oral health affects our
ability to eat, speak, smile, and show
emotions. Oral health also affects a
person’s self-esteem, school
performance, and attendance at work or
school. Oral diseases—which range
from cavities and gum disease to oral
cancer—cause pain and disability for
millions of Americans and cost
taxpayers billions of dollars each year.
CDC supports states in their efforts to
reduce oral disease and improve oral

E:\FR\FM\06MYN1.SGM

06MYN1